Annexin A2 (ANXA2) is an important host factor regulating several key processes in many viruses. To evaluate the potential involvement of ANXA2 in the life cycle of classical swine fever virus (CSFV), an RNA interference (RNAi) approach was utilized. Knockdown of ANXA2 did not impair CSFV RNA replication but significantly reduced CSFV production. A comparable reduction of extracellular and intracellular infectivity levels was detected, indicating that ANXA2 might play a role in CSFV assembly rather than in genome replication and virion release. Furthermore, ANXA2 was found to bind CSFV NS5A, an essential replicase component. Amino acids R338, N359, G378 of NS5A were revealed to be pivotal for the ANXA2-NS5A interaction. Substitutions of these amino acids had no effect on viral RNA replication but substantially reduced CSFV production, which might partly be due to these mutations destroying the ANXA2-NS5A interaction. These results suggested that ANXA2 might participate in CSFV production process by binding NS5A.
Classical swine fever virus (CSFV) is an important livestock pathogen and is a member of the genus Pestivirus, along with bovine viral diarrhea virus 1 (BVDV-1), BVDV-2, and border disease virus (BDV). They belong to the family Flaviviridae, which also contains the closely related human hepatitis C virus (HCV) (Heinz et al., 2000; Becher & Thiel, 2002) . CSFV is an enveloped positive-strand RNA virus. The virus contains a single-strand, positive-sense RNA genome, which is composed of a 59UTR, an ORF and a 39UTR. The 39UTR and the 59UTR are thought to regulate pestivirus genome replication (Isken et al., 2003 (Isken et al., , 2004 Xiao et al., 2004; Pankraz et al., 2005) . The 59UTR includes an internal ribosome entry site that is responsible for translation initiation of viral genomes (Fletcher & Jackson, 2002; Xiao et al., 2011) . The ORF codes for a resulting polyprotein that is subsequently processed into mature proteins (N pro , C, E rns , E1, E2, p7, NS2, NS3, NS4A, NS4B, NS5A and NS5B) by cellular and viral proteases (Moennig & Plagemann, 1992) . The CSFV NS5B protein has RNA-dependent RNA polymerase (RdRp) activity and is able to bind its cognate 39UTR and initiates genome replication (Steffens et al., 1999; Xiao et al., 2004) . NS5A is a component of the replication complex. CSFV NS5A comprises 497 aa and is able to regulate viral RNA replication and translation through binding to NS5B and 39UTR (Chen et al., 2012; Xiao et al., 2009) .
The viral life cycle requires various viral non-structural proteins as well as host cellular proteins. Annexin A2 (ANXA2) is known as a lipid raft-associated scaffold protein.
It is calcium dependent and cytosolic and mediates essential biological processes, including membrane trafficking, endosome formation, and aggregation of vesicles (Drust & Creutz, 1988) . ANXA2 has been identified as an important host factor in the regulation of several key processes in cytomegalovirus (Wright et al., 1995) , influenza virus (LeBouder et al., 2008) , calicivirus (González-Reyes et al., 2009), bluetongue virus (Beaton et al., 2002) , human immunodeficiency virus (Ryzhova et al., 2006) and HCV (Backes et al., 2010) . Recently, a proteomic analysis revealed that CSFV infection led to a significant increase of ANXA2 protein in host cells (Sun et al., 2008) . Haem oxygenase I, another cellular protein and ANXA2 were found to be colocalized with the CSFV E2 protein (Shi et al., 2009) . The expression of annexin A1, another member of the annexin family, was also elevated in PK-15 cells following CSFV infection (Sun et al., 2010) . However, the role of many cellular proteins in the life cycle of CSFV remains poorly understood. In this paper, we show that ANXA2 is involved in CSFV production.
To evaluate the potential involvement of ANXA2 in the life cycle of CSFV, an RNA interference (RNAi) approach and CSFV subgenomic replicons and genomic replicons (Sheng et al., 2010) (Fig. 1a) were utilized. A small interfering RNA (siRNA) molecule targeted to porcine ANXA2 sequence (GenBank accession no. NM_001005726) and a negative control siRNA molecule that has no matches either in the viral or the porcine genome were synthesized (Shanghai Gene Chem). An anti-CSFV siRNA directed to the CSFV NS5B gene served as a positive control (Xu et al., 2008) . Results showed that the ANXA2-specific siRNA reduced the amount of ANXA2 without a significant influence on the cell viability (results not shown) while the control siRNA, anti-CSFV siRNA and the mock transfection without siRNA addition did not (Fig. 1b) . Silencing ANXA2 did not reduce viral protein expression and RNA replication (Fig. 1b, c) . In contrast, substantial reduction in viral protein expression and RNA replication was observed for anti-CSFV siRNA treatment, indicating that the RNAi approach is efficient in controlling viral protein expression and RNA replication. Furthermore, the anti-ANXA2 siRNA resulted in a significant reduction of virus titre compared to that with the control siRNA and the treatment without siRNA (Fig. 1d) . These results showed that knockdown of ANXA2 did not impair CSFV RNA replication, but significantly reduced infectious CSFV production, suggesting that ANXA2 is involved in the production of infectious CSFV particles.
To examine the potential role of ANXA2 in the production of infectious CSFV particles, we analysed the effect of siRNA-mediated knockdown of ANXA2 on the extracellular and intracellular amounts of viral Core protein.
Lower levels of extracellular Core protein were detected for the cells transfected with anti-ANXA2 siRNA, while the amount of intracellular Core protein is comparable to the level for control siRNA treatment (Fig. 2a, b) . The anti-ANXA2 siRNA resulted in a significant reduction of extracellular Core proteins by about 70 % compared to that with the control siRNA (Fig. 2b ). These data indicated that ANXA2 is important for Core protein release from CSFV RNA transfected cells. The amount of Core protein released into cell supernatants is used as a surrogate measure of the production of infectious virus (Miyanari et al., 2007) , thus, ANXA2 is important for the production of infectious CSFV particles. This reduction in the amount of extracellular CSFV particles was due to a block in assembly or release. To address this question, we determined extracellular and intracellular infectivity levels by a TCID 50 assay. Anti-ANXA2 siRNAs significantly decreased extracellular and intracellular infectivity levels and a comparable reduction of extracellular and intracellular infectivity levels was observed (Fig. 2c ). We did not find an accumulation of intracellular infectious particles in the anti-ANXA2 siRNA transfected cells. Lower levels of specific infectivity (SI) of (Sheng et al., 2010) . (b, c) The indicated siRNAs were transfected into PK-15 cells using FuGENE HD Transfection Reagent (Roche) according to the manufacturer's protocol. Seventy-two hours after siRNA transfection, the transfected cells were retransfected with CSM" and a second dose of the same siRNA. Viral particles were not formed and newly synthesized viral RNAs were detected in CSM" transfected cells.
(b) Seventy-two hours after retransfection, cells were harvested. The cell lysates were subjected to 10 % SDS-PAGE. The amounts of ANXA2 (upper) and CSFV NS3 (below) in the cells transfected with the indicated siRNAs were evaluated by Western blot analysis (Sheng et al., 2012 ) with anti-ANXA2 or anti-NS3 antibody. b-Tubulin was used as an internal control and also for monitoring cytotoxicity (middle). (c) Cells were harvested at 24, 48 or 72 h after CSM" subgenomic replicon and siRNA transfection. Quantification of viral RNA was determined by using RT-qPCR . Relative replication efficiencies are shown. The CSM subgenomic replicon was used to normalize the data. (d) The indicated siRNAs were transfected into PK-15 cells. The transfected cells were retransfected with SM" and a second dose of the same siRNA. The retransfected cells were harvested at 24, 48 and 72 h post-transfection, and titres were determined by immunofluorescence . The arrowhead represents the detection limit of the assay. All quantified results are shown as means±SD of at least three independent experiments. ** P,0.01.
virions made in the presence of anti-ANXA2 siRNA were detected while release of virus RNA was comparable to the level for control siRNA treatment (Fig. 2d) . Taken together, these results indicated that a decrease in the production of infectious CSFV particles might be attributable to defective virion assembly rather than to virus release or RNA replication. The anti-ANXA2 siRNA treatment might not impair virus RNA, but result in virions with lower infectivity.
Previous reports showed that HCV NS5A is necessary for HCV assembly and production and interacts with ANXA2 (Appel et al., 2008; Masaki et al., 2008; Saxena et al., 2012) . To investigate whether ANXA2 interacts with CSFV NS5A, several NS5A mutants (Fig. 3a) formed in our previous work (Chen et al., 2012) were used for immunoprecipitation analysis. As shown in Fig. 3(b) , ANXA2 specifically coprecipitated CSFV NS5A. Mutant D335-389 lost ANXA2 binding activity but other NS5A mutants retained The relative values were shown by comparing densitometric values with the densitometric value for the SM replicon, which was set at 1. (c) Extracellular and intracellular infectivity levels were determined by TCID 50 assay as described in Fig. 1(d) . (d) Release of virus RNA from transfected cells 72 h posttransfection was determined by using reverse transcript-qPCR (RT-qPCR) as described in Fig. 1(c) . Specific infectivity (SI) was calculated as TCID 50 ml "1 /RNA copies. The SM was used to normalize the data. All quantified results are shown as means±SD of at least three independent experiments. ** P,0.01. the activity (Fig. 3b) , indicating that amino acids 335-389 might be important for ANXA2 binding. As a comparison, we aligned the NS5A sequences of CSFV, BDV, BVDV and HCV. Three conserved amino acids R338, N359 and G378 were indicated (Fig. 3c) , suggesting that these amino acids might be important for NS5A interactions with ANXA2. To corroborate this assumption, alanine or leucine substitutions were introduced into R338, N359 and G378 in CSFV NS5A. Four CSFV NS5A mutants, R338A, N359A, G378A and G378L were produced (Fig. 3d) . Immunoprecipitation assays revealed that ANXA2 binding activity was lost for R338A, N359A and G378L and was substantially reduced for G378A (Fig. 3e) . The results indicated that amino acids R338, N359 and G378 of CSFV NS5A are pivotal for the ANXA2-NS5A interaction. Furthermore, the same substitution mutations were incorporated into the CSM2 subgenomic replicon and the SM2 genomic replicon, respectively. These mutations had no substantial effect on viral RNA replication and viral protein expression (Fig. 3f) but substantially reduced CSFV production (Fig. 3g) . Immunoprecipitation of the NS5A-ANXA2 interaction was determined by Western blot analysis with anti-FLAG antibody or anti-ANXN A2 antibody as described in Fig. 3(b) . (f) PK-15 cells were transfected with the CSM" subgenomic replicon carrying WT or mutant NS5A proteins (R338A, N359A, G378A or G378L). Quantification of viral RNA was determined as described in Fig. 1(c) .
The amounts of NS3 (below) were evaluated as described in Fig. 1(b) . (g) PK-15 cells were transfected with the SM" subgenomic replicon carrying WT or mutant NS5A proteins (R338A, N359A, G378A or G378L). Titres were determined as described in Fig.  1(d) . All quantified results are shown as means±SD of at least three independent experiments. **P,0.01.
Host proteins participate in many aspects of viral infection. Vesicle-associated membrane protein-associated proteins mediate the formation of HCV RNA placation complex on lipid rafts . RNA helicase A, another host protein, has been found to be involved in the expression and replication of CSFV and bind CSFV 59UTR and 39UTR (Sheng et al., 2013) . Cellular NFAR proteins associate specifically with both the termini of the BVDV RNA genome involving regulatory elements (Isken et al., 2003) . ANXA2 is an important host protein that plays a role in different steps of viral life cycle (Backes et al., 2010; Beaton et al., 2002; González-Reyes et al., 2009; LeBouder et al., 2008; Ryzhova et al., 2006; Wright et al., 1995) . In the report, we identified ANXA2 as an important factor in the production of the CSFV infectious particles. ANXA2 also is a key host factor that influences HCV yield (Backes et al., 2010) . For the role of ANXA2 in viral RNA replication, scientists reported contradictory findings. Some people showed that ANXA2 knockdown reduced viral RNA replication (Saxena et al., 2012) while another observed that ANXA2 knockdown did not have this effect (Backes et al., 2010) . Our present results suggested that ANXA2 plays a role in CSFV assembly rather than in genome replication and virion release. The discrepancy may partly be due to the differences in virus species and in siRNA sequences.
The data for immunoprecipitation experiments showed that ANXA2 interacts with CSFV NS5A, in agreement with the previous reports in which ANXA2 binds HCV NS5A (Saxena et al., 2012) . The NS5A protein of CSFV, BVDV and HCV has been shown to be an essential replicase component (Masaki et al., 2008; Tellinghuisen et al., 2006; Sheng et al., 2010) , thus, ANXA2 might participate in the CSFV production process by binding to NS5A protein. In fact, ANXA2 has been found to be involved in the formation of HCV replication complex on the lipid raft (Saxena et al., 2012) . Mutation analysis revealed that amino acids 335-389 of NS5A might be responsible for ANXA2 binding (Fig. 3c, d ). NS5A is a multifunctional protein. The C terminus of CSFV NS5A contains several binding sites, such as a NS5B binding site and a 39UTR binding site ( Fig. 3a) (Chen et al., 2012) . Recently, we have found that the C-terminal sequence from amino acids 478-487 of NS5A is important for the interaction between CSFV NS5A and Core protein, which also might be related to the production of infectious CSFV particles (Sheng et al., 2014) . The amino acid fragment responsible for ANXA2 binding is adjacent to the NS5B binding site at the C terminus of CSFV NS5A (Fig. 3a) (Chen et al., 2012) . Furthermore, R338, N359 and G378 of CSFV NS5A were observed be pivotal for ANXA2-NS5A interactions (Fig. 3c,  e) . Substitution of these amino acids had no effect on viral RNA replication but substantially reduced CSFV production (Fig. 3f, g ), which might partly be due to this substitution destroying ANXA2-NS5A interactions. These results suggested that ANXA2 might participate in the CSFV production process by binding NS5A. This is attractive for further investigation of the role of ANXA2 in the life cycle of pestivirus and HCV.
